This report mainly focuses on branded generics market. Branded generics are generic drugs that have been given a proprietary market name. They may be marketed similarly to how branded drugs are. Branded generic drugs attach proprietary names to generic drug molecules.听
The global Branded Generics market is projected to grow from US$ 326 million in 2024 to US$ 523.1 million by 2030, at a Compound Annual Growth Rate (CAGR) of 8.2% during the forecast period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Covers:
This report presents an overview of global market for Branded Generics, sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Branded Generics, also provides the sales of main regions and countries. Highlights of the upcoming market potential for Branded Generics, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Branded Generics sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Branded Generics market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type, and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Branded Generics sales, projected growth trends, production technology, application and end-user industry.
Market Segmentation
By Company
Eva Pharmaceutical Industries
Pfizer
Sun Pharmaceutical Industries
Aspen Pharmacare Holding
Abbott Laboratories
Bausch Health
Segment by Type
Oral
Parenteral
Topical
Other
Segment by Application
Oncology
Cardiovascular Diseases
Diabetes
Neurology
Gastrointestinal Diseases
Others
Segment by Region
US & Canada
U.S.
Canada
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Europe
Germany
France
U.K.
Italy
Russia
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Branded Generics in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 3: Detailed analysis of Branded Generics manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, sales, and revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, sales, and revenue for each segment.
Chapter 8: China by Type, and by Application, sales, and revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, sales, and revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 11: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Branded Generics sales, revenue, price, gross margin, and recent development, etc.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: The main points and conclusions of the report.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Study Coverage
1.1 Branded Generics Product Introduction
1.2 Market by Type
1.2.1 Global Branded Generics Market Size Growth Rate by Type, 2019 VS 2023 VS 2030
1.2.2 Oral
1.2.3 Parenteral
1.2.4 Topical
1.2.5 Other
1.3 Market by Application
1.3.1 Global Branded Generics Market Size Growth Rate by Application, 2019 VS 2023 VS 2030
1.3.2 Oncology
1.3.3 Cardiovascular Diseases
1.3.4 Diabetes
1.3.5 Neurology
1.3.6 Gastrointestinal Diseases
1.3.7 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Branded Generics Sales Estimates and Forecasts 2019-2030
2.2 Global Branded Generics Revenue by Region
2.2.1 Global Branded Generics Revenue by Region: 2019 VS 2023 VS 2030
2.2.2 Global Branded Generics Revenue by Region (2019-2024)
2.2.3 Global Branded Generics Revenue by Region (2025-2030)
2.2.4 Global Branded Generics Revenue Market Share by Region (2019-2030)
2.3 Global Branded Generics Sales Estimates and Forecasts 2019-2030
2.4 Global Branded Generics Sales by Region
2.4.1 Global Branded Generics Sales by Region: 2019 VS 2023 VS 2030
2.4.2 Global Branded Generics Sales by Region (2019-2024)
2.4.3 Global Branded Generics Sales by Region (2025-2030)
2.4.4 Global Branded Generics Sales Market Share by Region (2019-2030)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufactures
3.1 Global Branded Generics Sales by Manufacturers
3.1.1 Global Branded Generics Sales by Manufacturers (2019-2024)
3.1.2 Global Branded Generics Sales Market Share by Manufacturers (2019-2024)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Branded Generics in 2023
3.2 Global Branded Generics Revenue by Manufacturers
3.2.1 Global Branded Generics Revenue by Manufacturers (2019-2024)
3.2.2 Global Branded Generics Revenue Market Share by Manufacturers (2019-2024)
3.2.3 Global Top 10 and Top 5 Companies by Branded Generics Revenue in 2023
3.3 Global Key Players of Branded Generics, Industry Ranking, 2022 VS 2023 VS 2024
3.4 Global Branded Generics Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Branded Generics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Branded Generics, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Branded Generics, Product Offered and Application
3.8 Global Key Manufacturers of Branded Generics, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Branded Generics Sales by Type
4.1.1 Global Branded Generics Historical Sales by Type (2019-2024)
4.1.2 Global Branded Generics Forecasted Sales by Type (2025-2030)
4.1.3 Global Branded Generics Sales Market Share by Type (2019-2030)
4.2 Global Branded Generics Revenue by Type
4.2.1 Global Branded Generics Historical Revenue by Type (2019-2024)
4.2.2 Global Branded Generics Forecasted Revenue by Type (2025-2030)
4.2.3 Global Branded Generics Revenue Market Share by Type (2019-2030)
4.3 Global Branded Generics Price by Type
4.3.1 Global Branded Generics Price by Type (2019-2024)
4.3.2 Global Branded Generics Price Forecast by Type (2025-2030)
5 Market Size by Application
5.1 Global Branded Generics Sales by Application
5.1.1 Global Branded Generics Historical Sales by Application (2019-2024)
5.1.2 Global Branded Generics Forecasted Sales by Application (2025-2030)
5.1.3 Global Branded Generics Sales Market Share by Application (2019-2030)
5.2 Global Branded Generics Revenue by Application
5.2.1 Global Branded Generics Historical Revenue by Application (2019-2024)
5.2.2 Global Branded Generics Forecasted Revenue by Application (2025-2030)
5.2.3 Global Branded Generics Revenue Market Share by Application (2019-2030)
5.3 Global Branded Generics Price by Application
5.3.1 Global Branded Generics Price by Application (2019-2024)
5.3.2 Global Branded Generics Price Forecast by Application (2025-2030)
6 US & Canada
6.1 US & Canada Branded Generics Market Size by Type
6.1.1 US & Canada Branded Generics Sales by Type (2019-2030)
6.1.2 US & Canada Branded Generics Revenue by Type (2019-2030)
6.2 US & Canada Branded Generics Market Size by Application
6.2.1 US & Canada Branded Generics Sales by Application (2019-2030)
6.2.2 US & Canada Branded Generics Revenue by Application (2019-2030)
6.3 US & Canada Branded Generics Market Size by Country
6.3.1 US & Canada Branded Generics Revenue by Country: 2019 VS 2023 VS 2030
6.3.2 US & Canada Branded Generics Sales by Country (2019-2030)
6.3.3 US & Canada Branded Generics Revenue by Country (2019-2030)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe Branded Generics Market Size by Type
7.1.1 Europe Branded Generics Sales by Type (2019-2030)
7.1.2 Europe Branded Generics Revenue by Type (2019-2030)
7.2 Europe Branded Generics Market Size by Application
7.2.1 Europe Branded Generics Sales by Application (2019-2030)
7.2.2 Europe Branded Generics Revenue by Application (2019-2030)
7.3 Europe Branded Generics Market Size by Country
7.3.1 Europe Branded Generics Revenue by Country: 2019 VS 2023 VS 2030
7.3.2 Europe Branded Generics Sales by Country (2019-2030)
7.3.3 Europe Branded Generics Revenue by Country (2019-2030)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China Branded Generics Market Size
8.1.1 China Branded Generics Sales (2019-2030)
8.1.2 China Branded Generics Revenue (2019-2030)
8.2 China Branded Generics Market Size by Application
8.2.1 China Branded Generics Sales by Application (2019-2030)
8.2.2 China Branded Generics Revenue by Application (2019-2030)
9 Asia (excluding China)
9.1 Asia Branded Generics Market Size by Type
9.1.1 Asia Branded Generics Sales by Type (2019-2030)
9.1.2 Asia Branded Generics Revenue by Type (2019-2030)
9.2 Asia Branded Generics Market Size by Application
9.2.1 Asia Branded Generics Sales by Application (2019-2030)
9.2.2 Asia Branded Generics Revenue by Application (2019-2030)
9.3 Asia Branded Generics Sales by Region
9.3.1 Asia Branded Generics Revenue by Region: 2019 VS 2023 VS 2030
9.3.2 Asia Branded Generics Revenue by Region (2019-2030)
9.3.3 Asia Branded Generics Sales by Region (2019-2030)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Branded Generics Market Size by Type
10.1.1 Middle East, Africa and Latin America Branded Generics Sales by Type (2019-2030)
10.1.2 Middle East, Africa and Latin America Branded Generics Revenue by Type (2019-2030)
10.2 Middle East, Africa and Latin America Branded Generics Market Size by Application
10.2.1 Middle East, Africa and Latin America Branded Generics Sales by Application (2019-2030)
10.2.2 Middle East, Africa and Latin America Branded Generics Revenue by Application (2019-2030)
10.3 Middle East, Africa and Latin America Branded Generics Sales by Country
10.3.1 Middle East, Africa and Latin America Branded Generics Revenue by Country: 2019 VS 2023 VS 2030
10.3.2 Middle East, Africa and Latin America Branded Generics Revenue by Country (2019-2030)
10.3.3 Middle East, Africa and Latin America Branded Generics Sales by Country (2019-2030)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Company Profiles
11.1 Mylan NV
11.1.1 Mylan NV Company Information
11.1.2 Mylan NV Overview
11.1.3 Mylan NV Branded Generics Sales, Price, Revenue and Gross Margin (2019-2024)
11.1.4 Mylan NV Branded Generics Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Mylan NV Recent Developments
11.2 Novartis AG
11.2.1 Novartis AG Company Information
11.2.2 Novartis AG Overview
11.2.3 Novartis AG Branded Generics Sales, Price, Revenue and Gross Margin (2019-2024)
11.2.4 Novartis AG Branded Generics Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Novartis AG Recent Developments
11.3 Eva Pharmaceutical Industries
11.3.1 Eva Pharmaceutical Industries Company Information
11.3.2 Eva Pharmaceutical Industries Overview
11.3.3 Eva Pharmaceutical Industries Branded Generics Sales, Price, Revenue and Gross Margin (2019-2024)
11.3.4 Eva Pharmaceutical Industries Branded Generics Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Eva Pharmaceutical Industries Recent Developments
11.4 Pfizer
11.4.1 Pfizer Company Information
11.4.2 Pfizer Overview
11.4.3 Pfizer Branded Generics Sales, Price, Revenue and Gross Margin (2019-2024)
11.4.4 Pfizer Branded Generics Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Pfizer Recent Developments
11.5 Sun Pharmaceutical Industries
11.5.1 Sun Pharmaceutical Industries Company Information
11.5.2 Sun Pharmaceutical Industries Overview
11.5.3 Sun Pharmaceutical Industries Branded Generics Sales, Price, Revenue and Gross Margin (2019-2024)
11.5.4 Sun Pharmaceutical Industries Branded Generics Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Sun Pharmaceutical Industries Recent Developments
11.6 Aspen Pharmacare Holding
11.6.1 Aspen Pharmacare Holding Company Information
11.6.2 Aspen Pharmacare Holding Overview
11.6.3 Aspen Pharmacare Holding Branded Generics Sales, Price, Revenue and Gross Margin (2019-2024)
11.6.4 Aspen Pharmacare Holding Branded Generics Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Aspen Pharmacare Holding Recent Developments
11.7 Abbott Laboratories
11.7.1 Abbott Laboratories Company Information
11.7.2 Abbott Laboratories Overview
11.7.3 Abbott Laboratories Branded Generics Sales, Price, Revenue and Gross Margin (2019-2024)
11.7.4 Abbott Laboratories Branded Generics Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Abbott Laboratories Recent Developments
11.8 Bausch Health
11.8.1 Bausch Health Company Information
11.8.2 Bausch Health Overview
11.8.3 Bausch Health Branded Generics Sales, Price, Revenue and Gross Margin (2019-2024)
11.8.4 Bausch Health Branded Generics Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Bausch Health Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Branded Generics Industry Chain Analysis
12.2 Branded Generics Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Branded Generics Production Mode & Process
12.4 Branded Generics Sales and Marketing
12.4.1 Branded Generics Sales Channels
12.4.2 Branded Generics Distributors
12.5 Branded Generics Customers
13 Market Dynamics
13.1 Branded Generics Industry Trends
13.2 Branded Generics Market Drivers
13.3 Branded Generics Market Challenges
13.4 Branded Generics Market Restraints
14 Key Findings in The Global Branded Generics Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
Mylan NV
Novartis AG
Eva Pharmaceutical Industries
Pfizer
Sun Pharmaceutical Industries
Aspen Pharmacare Holding
Abbott Laboratories
Bausch Health
听
听
*If Applicable.